GLP-1 Medications May Increase the Risk of Severe Acid Reflux

• July 18, 2025
• HealthDayTV HealthDay Reporter

A new study finds patients with type 2 diabetes who take GLP-1 receptor agonists are 27% more likely to develop gastroesophageal reflux disease (GERD) compared to those taking other common drugs called SGLT-2 inhibitors.

Health News is provided as a service to Pharmcare Pharmacy LTC site users by HealthDay. Pharmcare Pharmacy LTC nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Tags